[…]Addiction Medicine American Board of Addiction Medicine Medical Education and Research Foundation for the Treatment of Alcoholism and Other Drug Dependencies (MERF) California Public Protection and Physician Health, Inc. (CPPPH) Related Resources – Visit sites below for more on addiction American Association for the Treatment of Opiate Dependence Addiction Technology Transfer Center Alcohol Addiction Center APA Division on Psychopharmacology Center for Education and Drug Abuse Center for Substance Abuse Treatments (CSAT) Drug Policy Alliance Ensuring Solutions to Alcohol Problems Ernest Gallo Clinic and Research Center Mental Health Resource Narcotics Anonymous National Alliance of Advocates for Buprenorphine Treatment The National Center on […]
[…]on addressing questions patients frequently ask their physicians about its use, and based on up-to-date science, suggest ways to improve physician-patient discussions about cannabis and apply them to a clinical setting. Presenter: Itai Danovitch, MD Dr. Danovitch is President of the California Society of Addiction Medicine, and Chair for the Department of Psychiatry and Director of Addiction Psychiatry at Cedars Sinai Medical Center. His research interests have focused on substance use disorders, particularly marijuana, as well as the integration of medical and mental health services. Educational Objectives Upon completion of this program, participants should be able to: Answer patientsā questions […]
[…]diabetic. All too often CSAM physicians see their patients work towards a false goal of medication-free abstinence that is reinforced by societal prejudice and a system of reimbursement that pays for detoxification but not maintenance. When patients risk relapse back to illicit opiates, they jeopardize relationships with the ones they love. Patients who relapse back to opiate addiction endanger their jobs, threaten their quality of life, and most importantly, imperil their health. The risks of relapse are especially dangerous amidst the current HIV and hepatitis C epidemics Methadone maintenance is a treatment for opiate addiction that is safe, efficacious, and […]
[…]of Medical Specialties (ABMS). Additionally, the locator lists the specialty information for each member (as supplied by the member) and information about each member’s current positions. Only current CSAM members are listed in the locator. If you are a physician, addiction medicine professional, or a medical student and would like to be included in the physician locator, the first step is to join ASAM/CSAMĀ here. If you would like to be removed from the listing, please notify us here. Consumer […]
[…]all of which CSAM supports: AB 2651 (Bains) Support AB 2651 would create, upon appropriation by the Legislature, the Licensed Alcohol Drug Counselor Board within the Department of Consumer Affairs. The bill would require the board to establish regulations and standards for the licensure of alcohol drug counselors, as specified. The bill would authorize the board to collaborate with the Department of Health Care Access and Information regarding behavioral health professions, review sunrise review applications for emerging behavioral health license and certification programs and refer complaints regarding behavioral health workers to appropriate agencies, as specified. AB 2115 (Haney) Support Under current law, […]
[…]of Preventive Medicine, Addiction Medicine Subspecialty Board Exam in 2024. Our other Wednesday Pre-conference workshops will focus on psychedelics, the state of the art in opioid use disorder treatment, addressing our child and adolescent populations, while MERF (Medical Education Research Foundation) will offer its popular MI (Motivational Interviewing) workshop on Wednesday as well. And last but not the least, MERF scholars and conference attendees will have an opportunity to share their research and other projects through multiple Poster Sessions over the course of conference. In short, whether you are a late, mid or early career physician, a physician in training, […]
[…]pleased to announce that we are hard at work developing our small group case discussions, a time-honored CSAM tradition. Our attendees consistently tell us that this is one of the many things that set CSAM conferences apart, as these discussions enhance both learning and community building. We have been asked over the years why the case discussions donāt include outcomes and I had the opportunity to discuss this with Dr. Steve Eickelberg, who is one of our cherished long-term CSAM members and who has written so many of the cases that you have been challenged by over the years. Hereās […]
[…]in high amounts or with high frequency, is not equivalent to a substance use disorder b) The DSM-5-TR distinguishes between substance use and SUDs which should not necessarily be equated c) The frequency, duration, and amount of substance use alone have never been diagnostic criteria in the DSM, because those metrics do not correlate with a lack of control d) A positive drug test alone is not an indicator of a substance use disorder and e) substance use disorders are clinical conditions that should only be diagnosed by trained professionals and not the courts. This latter amicus was filed with […]
[…]over the last 15 years-that this view of cannabinoid action on brain reward processes and reward-related behaviors is untenable. This paper reviews those data, and concludes that cannabinoids act on brain reward processes and reward-related behaviors in strikingly similar fashion to other addictive drugs. Pistis, M., Muntoni, A. L., Pillolla, G., Gessa, G. L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological studyEur J Neurosci. 2002 Jun;15(11):1795-802. Abstract The nucleus accumbens (NAc) represents a critical site for the rewarding properties of diverse classes of drugs of abuse. Glutamatergic afferents to the […]